feed,title,long_url,short_url
Benzinga,Longeveron Shares Gain After Lead Product Gets FDA Orphan Drug Tag For Type Of Congenital Heart Defect,https://benzinga.com/general/biotech/21/12/24426342/longeveron-shares-gain-after-lead-product-gets-fda-orphan-drug-tag-for-type-of-congenital-heart-d,https://j.mp/3pqULuP
